These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26347531)

  • 21. Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models.
    Markovic S; Roussel T; Agemy L; Sasson K; Preise D; Scherz A; Frydman L
    NMR Biomed; 2021 Sep; 34(9):e4569. PubMed ID: 34137085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvate.
    Josan S; Billingsley K; Orduna J; Park JM; Luong R; Yu L; Hurd R; Pfefferbaum A; Spielman D; Mayer D
    NMR Biomed; 2015 Dec; 28(12):1671-7. PubMed ID: 26474216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperpolarised
    Arponen O; Wodtke P; Gallagher FA; Woitek R
    Eur J Radiol; 2023 Oct; 167():111058. PubMed ID: 37666071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas.
    Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A
    Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.
    Morgan TK; Hardiman K; Corless CL; White SL; Bonnah R; Van de Vrugt H; Sheppard BC; Grompe M; Cosar EF; Streeter PR
    Cancer Cytopathol; 2013 Jan; 121(1):37-46. PubMed ID: 22811080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer.
    Schmahl MJ; Regan DP; Rivers AC; Joesten WC; Kennedy MA
    PLoS One; 2018; 13(7):e0200658. PubMed ID: 30016349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.
    Habbe N; Shi G; Meguid RA; Fendrich V; Esni F; Chen H; Feldmann G; Stoffers DA; Konieczny SF; Leach SD; Maitra A
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18913-8. PubMed ID: 19028870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice.
    Smith JP; Cooper TK; McGovern CO; Gilius EL; Zhong Q; Liao J; Molinolo AA; Gutkind JS; Matters GL
    Pancreas; 2014 Oct; 43(7):1050-9. PubMed ID: 25058882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust hyperpolarized (13)C metabolic imaging with selective non-excitation of pyruvate (SNEP).
    Chen WC; Teo XQ; Lee MY; Radda GK; Lee P
    NMR Biomed; 2015 Aug; 28(8):1021-30. PubMed ID: 26119950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
    Fendrich V; Schneider R; Maitra A; Jacobsen ID; Opfermann T; Bartsch DK
    Neoplasia; 2011 Feb; 13(2):180-6. PubMed ID: 21403843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
    Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
    Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
    Iakovlev V; Siegel ER; Tsao MS; Haun RS
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic biomarkers for non-alcoholic fatty liver disease induced by high-fat diet: In vivo magnetic resonance spectroscopy of hyperpolarized [1-
    Moon CM; Oh CH; Ahn KY; Yang JS; Kim JY; Shin SS; Lim HS; Heo SH; Seon HJ; Kim JW; Jeong GW
    Biochem Biophys Res Commun; 2017 Jan; 482(1):112-119. PubMed ID: 27562716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical importance of precursor lesions in the pancreas.
    Hruban RH; Takaori K; Canto M; Fishman EK; Campbell K; Brune K; Kern SE; Goggins M
    J Hepatobiliary Pancreat Surg; 2007; 14(3):255-63. PubMed ID: 17520200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms: the interest of endoscopic ultrasonography.
    Maire F; Couvelard A; Palazzo L; Aubert A; Vullierme MP; Rebours V; Hammel P; Sauvanet A; Levy P; Ruszniewski P
    Pancreas; 2013 Nov; 42(8):1262-6. PubMed ID: 24152960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
    Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of variable stages in murine pancreatic tumors by a multiparametric approach employing hyperpolarized
    Martinho RP; Bao Q; Markovic S; Preise D; Sasson K; Agemy L; Scherz A; Frydman L
    NMR Biomed; 2021 Feb; 34(2):e4446. PubMed ID: 33219722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.